ATC code M05

ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1][2][3] Subgroup M05 is part of the anatomical group M Musculo-skeletal system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM05.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M05B Drugs affecting bone structure and mineralization

M05BA Bisphosphonates

M05BA01 Etidronic acid

M05BA02 Clodronic acid

M05BA03 Pamidronic acid

M05BA04 Alendronic acid

M05BA05 Tiludronic acid

M05BA06 Ibandronic acid

M05BA07 Risedronic acid

M05BA08 Zoledronic acid

M05BB Bisphosphonates, combinations

M05BB01 Etidronic acid and calcium, sequential

M05BB02 Risedronic acid and calcium, sequential

M05BB03 Alendronic acid and colecalciferol

M05BB04 Risedronic acid, calcium and colecalciferol, sequential

M05BB05 Alendronic acid, calcium and colecalciferol, sequential

M05BB06 Alendronic acid and alfacalcidol, sequential

M05BB07 Risedronic acid and colecalciferol

M05BB08 Zoledronic acid, calcium and colecalciferol, sequential

M05BB09 Ibandronic acid and colecalciferol

M05BC Bone morphogenetic proteins

M05BC01 Dibotermin alfa

M05BC02 Eptotermin alfa

M05BX Other drugs affecting bone structure and mineralization

M05BX01 Ipriflavone

M05BX02 Aluminium chlorohydrate

M05BX03 Strontium ranelate

M05BX04 Denosumab

M05BX05 Burosumab

M05BX06 Romosozumab

M05BX07 Vosoritide

M05BX08 Menatetrenone

M05BX53 Strontium ranelate and colecalciferol